D'Agostino GR, Badalamenti M, Stefanini S, Baldaccini D, et al. Long term update on toxicity and survival of a phase II trial of linac-based stereotactic body radiation therapy for low-intermediate risk prostate cancer. Prostate 2023 Dec 19. doi: 10.1002/pros.24657.
PMID: 38112222